Certara Inc. Common Stock is a global leader in biosimulation, helping companies in the pharmaceutical and biotechnology industries accelerate drug development and make better data-driven decisions. With a comprehensive suite of software solutions and consulting services, Certara empowers scientists to predict the safety and efficacy of new treatments with remarkable accuracy.